COMPLETED

Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Laser treatment of hypertrophic burn scars has become increasingly popular for improving scarring in burn survivors. Despite its common use, there a gap in knowledge regrading randomized control trials that demonstrate whether the laser is beneficial. Such a trial is important because if it shows the laser does work, it would provide the evidence to make such treatments more accessible to all patients. Furthermore, there is no knowledge whether the burn injury used to remove tissue is beneficial or not. This study aims to evaluate the laser treatment, removal of similar tissue amounts with 0.5mm punch biopsies, to controls to fill this knowledge gap. The hypothesis is the laser is beneficial at improving patient's burn scars. Also the punch biopsies work better at improving scars by removing tissue without burning and injuring the surrounding tissue as the laser does. To evaluate these treatments (laser, punch biopsies, and no treatment), 3 small areas will be chosen in a study scar area that meets specific criteria to receive . Patients will still be able to receive laser and burn reconstruction procedures in all other areas not involving the study scar area that are clinically indicated. In the study, the scar will be evaluated with photographs, surveys, and tissue samples taken either while under anesthesia except for one set taken with numbing medicine. The tissue samples will be looked at under a microscope to see how the treatments change the scar tissue. The tissue will also have tests done to evaluate how the laser impacts genes from cells in the scar tissue. Lastly, to understand how reconstructive procedures (laser and surgical treatments) change a patient's quality of life, patients will be asked a limited set of questions to learn more how these procedures improve their lives.

Official Title

A Within-Scar, Randomized Control Trial Comparing Fractional Ablative Carbon Dioxide Laser to Non-Energy-Based, Mechanical Tissue Extraction and No Treatment

Quick Facts

Study Start:2019-03-20
Study Completion:2025-10-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT03692273

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients must be 18 years of age or older
  2. * Must be medically fit to undergo laser/reconstructive procedure
  3. * Must have symptomatic HTBS for which they are already planning to undergo laser treatment. The symptomatic HTBSs may include the study scar area, but there must be other areas that the patient is getting treated with laser besides the study scar.
  4. * The HTBS must have occurred from a burn injured area either treated by skin grafts or allowed to heal secondarily.
  5. * Be willing and able to participate in the study with a year of follow-up
  6. * Must be able to answer surveys on their own, and not rely on surrogates
  7. * Not be pregnant or planning to become pregnant during the treatment phase of the study
  1. * Previous laser or reconstructive procedures for the treatment of their HTBS in the study scar or adjacent tissue.
  2. * Steroids, immunosuppressive medications, chemotherapy or other medications that can delay their wound healing/immune function.
  3. * Medical Conditions that preclude laser treatment or general anesthesia if needed
  4. * Cognitively unable to complete PROMs on their own
  5. * The study area should not be part of a contracture or other hypertrophic scar that would be better treated with surgical procedures.
  6. * The study scar must not be adjacent to/in continuity with areas of HTBS that are planning to be treated with surgical interventions.

Contacts and Locations

Principal Investigator

Jonathan Friedstat, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Jonathan Friedstat, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-03-20
Study Completion Date2025-10-06

Study Record Updates

Study Start Date2019-03-20
Study Completion Date2025-10-06

Terms related to this study

Additional Relevant MeSH Terms

  • Burns
  • Hypertrophic Scar